ClinicalTrials.Veeva

Menu

Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design

CooperVision logo

CooperVision

Status

Completed

Conditions

Ametropia

Treatments

Device: Lens A
Device: Lens B

Study type

Interventional

Funder types

Industry

Identifiers

NCT05516082
EX-MKTG-141

Details and patient eligibility

About

This was a single-blind, interventional, prospective, direct refit, bilateral wear, fixed-sequence crossover study.

Full description

The aim of this study was to evaluate the visual performance and subjective experiences of daily disposable hydrogel lens (DDH) when compared to daily disposable silicone hydrogel lens (DDSH) after 15 minutes of daily wear each.

Enrollment

41 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Has read and signed an information consent letter.
  • Self-reports having a full eye examination in the previous two years.
  • Anticipates being able to wear the study lenses for the required time of the study.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Has refractive astigmatism no higher than -0.75 DC.
  • Can be fit with the available lens parameters (sphere +8.00 to -10.00D).
  • Can achieve binocular distance vision of at least 20/30 Snellen (logMAR 0.18) with the study contact lenses.

Exclusion criteria

  • Is participating in any concurrent clinical or research study.
  • Has any known active ocular disease and/or infection that contraindicates contact lens wear.
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable.
  • Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable.
  • Has known sensitivity to the diagnostic sodium fluorescein used in the study.
  • Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment.
  • Has undergone refractive error surgery or intraocular surgery.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

41 participants in 2 patient groups

Lens A
Experimental group
Description:
All participants wore Lens A for 15 minutes (Period 1)
Treatment:
Device: Lens A
Lens B
Experimental group
Description:
All participants wore Lens B for 15 minutes (Period 2)
Treatment:
Device: Lens B

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

José A Vega, OD,MSc,FAAO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems